Michael J. Sofia
Insider
First SEC filing: March 16, 2015 · Latest: March 16, 2015
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 2, 2024 | ABUS | S 10b5-1 | 9,982 | $2.31 | $23,058 | 1,485,121 Direct | -0.67% | Disposed | 92.6% (price as of 2026-10-02) |
| Feb. 1, 2024 | ABUS | A | 109,500 | · | · | 1,495,103 Direct | +7.90% | Acquired | (price as of 2026-10-02) |
| Feb. 1, 2024 | ABUS | A | 437,800 | · | · | 437,800 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 1, 2023 | ABUS | A | 82,200 | · | · | 1,385,603 Direct | +6.31% | Acquired | (price as of 2026-10-02) |
| Feb. 1, 2023 | ABUS | A | 328,700 | · | · | 328,700 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 20, 2022 | ABUS | A | 285,000 | $2.81 | $800,850 | 285,000 Direct | · | Acquired | 58.4% (price as of 2026-10-02) |
| Dec. 1, 2021 | ABUS | S 10b5-1 | 200,000 | $5.09 | $1,018,000 | 1,303,403 Direct | -13.30% | Disposed | -12.6% (price as of 2026-10-02) |
| Feb. 13, 2021 | ABUS | A | 290,000 | · | · | 290,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 17, 2020 | ABUS | A | 250,000 | · | · | 250,000 Direct | · | Acquired | (price as of 2026-10-02) |
| March 1, 2019 | ABUS | A | 145,000 | · | · | 145,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 13, 2018 | ABUS | S | 4,250 | $9.51 | $40,418 | 167,162 Indirect | -2.48% | Disposed | -53.2% (price as of 2026-10-02) |
| Aug. 13, 2018 | ABUS | S | 4,250 | $9.51 | $40,418 | 1,499,153 Direct | -0.28% | Disposed | -53.2% (price as of 2026-10-02) |
| July 11, 2018 | ABUS | S 10b5-1 | 10,000 | $10.00 | $100,000 | 1,503,403 Direct | -0.66% | Disposed | -55.5% (price as of 2026-10-02) |
| July 9, 2018 | ABUS | S 10b5-1 | 10,000 | $8.91 | $89,100 | 1,513,403 Direct | -0.66% | Disposed | -50.1% (price as of 2026-10-02) |
| July 6, 2018 | ABUS | S 10b5-1 | 10,000 | $8.45 | $84,500 | 1,523,403 Direct | -0.65% | Disposed | -47.3% (price as of 2026-10-02) |
| July 5, 2018 | ABUS | S 10b5-1 | 10,000 | $8.40 | $84,000 | 1,533,403 Direct | -0.65% | Disposed | -47.0% (price as of 2026-10-02) |
| July 3, 2018 | ABUS | S 10b5-1 | 10,000 | $8.00 | $80,000 | 1,543,403 Direct | -0.64% | Disposed | -44.4% (price as of 2026-10-02) |
| April 16, 2018 | ABUS | A | 160,000 | · | · | 160,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Oct. 3, 2017 | ABUS | S 10b5-1 | 10,000 | $8.00 | $80,000 | 1,553,403 Direct | -0.64% | Disposed | -44.4% (price as of 2026-10-02) |
| Aug. 15, 2017 | ABUS | S | 20,000 | $3.68 | $73,600 | 171,412 Indirect | -10.45% | Disposed | 20.9% (price as of 2026-10-02) |
| Aug. 15, 2017 | ABUS | S | 10,000 | $3.75 | $37,500 | 191,412 Indirect | -4.96% | Disposed | 18.7% (price as of 2026-10-02) |
| March 24, 2017 | ABUS | A | 150,000 | · | · | 150,000 Direct | · | Acquired | (price as of 2026-10-02) |
| March 15, 2016 | ABUS | A | 100,000 | · | · | 100,000 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 1, 2024 | ABUS | Stock Option (Right to Buy) | Common Shares | · | Feb. 1, 2034 | 437,800 | Acquired |
| Feb. 1, 2023 | ABUS | Stock Option (Right to Buy) | Common Shares | $2.90 | Feb. 1, 2033 | 328,700 | Acquired |
| Jan. 20, 2022 | ABUS | Stock Option (Right to Buy) | Common Shares | $2.81 | Jan. 20, 2032 | 285,000 | Acquired |
| Feb. 13, 2021 | ABUS | Stock Options | Common Stock | $4.33 | Feb. 13, 2031 | 290,000 | Acquired |
| Feb. 17, 2020 | ABUS | Stock Options | Common Stock | $3.35 | Feb. 17, 2030 | 250,000 | Acquired |
| March 1, 2019 | ABUS | Employee Stock Option (Right to Buy) | Common Shares | $4.57 | March 1, 2029 | 145,000 | Acquired |
| April 16, 2018 | ABUS | Employee Stock Option (Right to Buy) | Common Stock | $5.20 | April 16, 2028 | 160,000 | Acquired |
| March 24, 2017 | ABUS | Employee Stock Option (Right to Buy) | Common Stock | $3.15 | March 24, 2027 | 150,000 | Acquired |
| March 15, 2016 | ABUS | Employee Stock Option (Right to Buy) | Common Shares | $3.94 | March 15, 2026 | 100,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2023 | $492,000 | · | $238,380 | $720,208 | $147,600 | · | $16,500 | $1,614,688 |
| 2022 | $468,000 | · | · | $619,775 | $149,760 | · | $10,675 | $1,248,210 |
| 2021 | $452,100 | · | · | $938,944 | $207,966 | · | $10,150 | $1,609,160 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.